Wine and Stocks

AstraZeneca profit climbs on cancer and heart drug demand

by

The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *